Jump to content

Robert J. Linhardt

From Wikipedia, the free encyclopedia

This is the current revision of this page, as edited by PrimeBOT (talk | contribs) at 20:22, 12 October 2023 (top: Task 30: parameter removal following discussion). The present address (URL) is a permanent link to this version.

(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)
Robert J. Linhardt
Linhardt in his RPI lab in 2011
Alma materMIT
Johns Hopkins University
Marquette University
AwardsScientific American 10
American Chemical Society Melville L. Wolfrom Award
American Chemical Society Claude S. Hudson Award
American Chemical Society Horace S. Isbell
AAAS Fellow
Scientific career
FieldsBioengineering
Metabolic Engineering
Biomolecular Interaction
The Interactome
Carbohydrate Analysis
Structural Biology
Glycobiology
Glycomics
Synthetic Carbohydrate Chemistry
Nanobiotechnology
Nano/Micron-scale Devices
InstitutionsRensselaer Polytechnic Institute
Academic advisorsRobert S. Langer
Brown L. Murr

Robert J. Linhardt is the Ann and John Broadbent, Jr. '59 Senior Constellation Professor Biocatalysis & Metabolic Engineering at Rensselaer Polytechnic Institute.

His primary appointment at RPI is based in the Center for Biotechnology and Interdisciplinary Studies, consisting of joint appointments with the Department of Chemistry & Chemical Biology, Department of Biology, Department of Chemical and Biological Engineering, Department of Biomedical Engineering and the Rensselaer Nanotechnology Center. He is highly cited in his field, with over 100 papers having each over 100 citations.[1]

Prior to joining RPI in 2003, he was then a professor for 21 years at the University of Iowa. During his career in Iowa, he spent eight years as the F. Wendell Miller Distinguished Professor of Chemistry and ten years as a member of the executive committee of the Center for Biocatalysis & Bioprocessing.[2] Since 2008 Linhardt's group has been working on a collaboration to bioengineer Heparin from E. coli. This is in part a response to the outbreak of adverse heparin reactions in 2007.[3] This work helped earn him a spot in the Scientific American 10, for the 10 people who “demonstrated outstanding commitment to assuring that the benefits of new technologies and knowledge will accrue to humanity.”[4][5] He was the 2010 recipient of the Melville L. Wolfrom Award of the American Chemical Society.[6]

References

[edit]
  1. ^ "Robert J. Linhardt". Retrieved November 1, 2017.
  2. ^ "Robert J. Linhardt". NY.gov. Retrieved November 1, 2017.
  3. ^ Blossom, DB; Kallen, AJ; Patel, PR; Elward, A; Robinson, L; Gao, G; Langer, R; Perkins, KM; Jaeger, JL; Kurkjian, KM; Jones, M; Schillie, SF; Shehab, N; Ketterer, D; Venkataraman, G; Kishimoto, TK; Shriver, Z; McMahon, AW; Austen, KF; Kozlowski, S; Srinivasan, A; Turabelidze, G; Gould, CV; Arduino, MJ; Sasisekharan, R (Dec 2008). "Outbreak of adverse reactions associated with contaminated heparin". N Engl J Med. 359 (25): 2674–84. doi:10.1056/NEJMoa0806450. PMC 3810025. PMID 19052120.
  4. ^ "Robert Linhardt Named One of the Scientific American 10 | News & Events". news.rpi.edu.
  5. ^ "Scientific American 10: Guiding Science for Humanity". Scientific American. June 2009. Retrieved 17 February 2012.
  6. ^ "Rensselaer Professor Robert Linhardt Wins American Chemical Society's Wolfrom Award". Rensselaer Polytechnic Institute. April 1, 2010. Retrieved January 25, 2019.
[edit]